Company intelligence / Profile preview
Indivior
Chesterfield, Virginia, United Statesindivior.com ↗
- Ownership
- Public · INDV
- Employees
- ~1030
- Development stage
- Other
01
Overview
Indivior has developed and commercialized several leading treatments for opioid dependence, including Suboxone (buprenorphine/naloxone), Subutex (buprenorphine), Sublocade (extended-release buprenorphine injection), and OPVEE nasal spray. The company’s portfolio addresses opioid use disorder with both daily oral and monthly injectable options. Recent clinical advances include label expansions for Sublocade to support rapid initiation protocols.[1][5]
- Therapeutic areas
- Psychiatry
- Modalities
- Small molecules (notably buprenorphine and naloxone formulations)[1][5]
- Industry
- Biotech
02
Drug pipeline
18 assets17 more assets in the full pipeline.
03
Partnerships
Co-development agreement with AntiOp, Inc. for a naloxone nasal spray product; licensing agreements for schizophrenia treatment distribution in Canada.[4] Also contracts with U.S. Biomedical Advanced Research and Development Authority for OPVEE supply.[5]
04
Financials
- Market cap
- $4.5B
- Total revenue
- $1.2B
- Enterprise value
- $4.7B
Beyond the preview
Go deeper on Indivior.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Indivior.